Advancing Therapies for Cancer—From Mustard Gas to CAR T
The development of targeted therapeutics for cancer continues to receive intense research attention as laboratories and pharmaceutical companies seek to develop drugs and technologies that improve treatment efficacy and mitigate harmful side effects. In the aftermath of World War I, it was discovere...
Main Authors: | Dillon K. Jarrell, Seth Drake, Mark A. Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Sci |
Subjects: | |
Online Access: | https://www.mdpi.com/2413-4155/2/4/90 |
Similar Items
-
Editorial: Advances in molecular classification and targeting of solid tumors
by: Manoj Pandey, et al.
Published: (2024-02-01) -
Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
by: Michal Kýr, et al.
Published: (2020-03-01) -
Personalized Medicine: Recent Progress in Cancer Therapy
by: Valentina Gambardella, et al.
Published: (2020-04-01) -
Targeted Therapy Development in Acute Myeloid Leukemia
by: Tulasigeri M. Totiger, et al.
Published: (2023-02-01) -
The role of molecular tumor boards in neuro-oncology: a nationwide survey
by: Lisa S. Hönikl, et al.
Published: (2024-01-01)